Unusual features of gastrointestinal stromal tumor on PET/CT and CT imaging

Clinical Nuclear Medicine

Volumn 36, Issue 3, 2011, Pages

  Wong, Chun Sing ^a   Tiffany Chu, Yiu Ching ^b   Khong, Pek Lan ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b KWONG WAH HOSPITAL   (Hong Kong)

Author keywords

gastrointestinal stromal tumor; imatinib; intestinal obstruction rupture; lymphatic metastasis; pancreatic neoplasm; prostatic neoplasm

Indexed keywords

IMATINIB;

ARTICLE; BONE METASTASIS; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DELAYED DIAGNOSIS; DISEASE ASSOCIATION; DISEASE CONTROL; DRUG EFFICACY; EARLY DIAGNOSIS; ESOPHAGUS TUMOR; FOLLOW UP; GASTROINTESTINAL STROMAL TUMOR; HUMAN; INTESTINE OBSTRUCTION; LYMPH NODE METASTASIS; PANCREAS TUMOR; POSITRON EMISSION TOMOGRAPHY; PROGNOSIS; PROSTATE TUMOR; RECTUM TUMOR; TUMOR LOCALIZATION; TUMOR RUPTURE;

CHILD; GASTROINTESTINAL STROMAL TUMORS; HUMANS; NEOPLASM METASTASIS; POSITRON-EMISSION TOMOGRAPHY; TOMOGRAPHY, X-RAY COMPUTED;

EID: 79951559271     PISSN: 03639762     EISSN: None     Source Type: Journal    
DOI: 10.1097/RLU.0b013e31820aa233     Document Type: Article

References (66)

1. Levy AD, Remotti HE, Thompson WM, et al. Gastrointestinal stromal tumors: radiologic features with pathologic correlation. Radiographics. 2003; 23:283-304. (Pubitemid 37431262)
2. Demetri GD, Benjamin RS, Blanke CD, et al. NCCN task force report: optimal management of patients with gastrointestinal stromal tumor (GIST)-update of the NCCN clinical practice guidelines. J Natl Compr Cancer Netw. 2007;5(suppl 2)S1-S29.
3. Burkill GJ, Badran M, Al-Muderis O, et al. Malignant gastrointestinal stromal tumor: distribution, imaging features, and pattern of metastatic spread. Radiology. 2003;226:527-532. (Pubitemid 36313445)
4. Fletcher CD, Berman JJ, Corless C, et al. Diagnosis of gastrointestinal stromal tumors: a consensus approach. Int J Surg Pathol. 2002;10:81-89. (Pubitemid 34655094)
5. Miettinen M, Lasota J. Gastrointestinal stromal tumors: pathology and prognosis at different sites. Semin Diagn Pathol. 2006;23:71-83.
6. Kindblom LG, Remotti HE, Aldenborg F, et al. Gastrointestinal pacemaker cell tumor (GIPACT): gastrointestinal stromal tumors show phenotypic characteristics of the interstitial cells of Cajal. Am J Pathol. 1998;152:1259-1269. (Pubitemid 28221878)
7. Sanders KM, Ward SM. Interstitial cell of Cajal: a new perspective on smooth muscle function. J Physiol. 2006;576(pt 3):721-726. (Pubitemid 44637878)
8. Miettinen M, Majidi M, Lasota J. Pathology and diagnostic criteria of gastrointestinal stromal tumors (GISTs): a review. Eur J Cancer. 2002; 38(suppl 5):S39-S51.
9. Machado-Aranda D, Malamet M, Chang YJ, et al. Prevalence and management of gastrointestinal stromal tumors. Am Surg. 2009;75:55-60.
10. Fernandez Salazar LI, Alvarez Gago T, Sans Rubiales A, et al. Gastrointestinal stromal tumors (GISTs): clinical aspects. Rev Esp Enferm Dig (Madrid). 2007;99:19-24. (Pubitemid 350271636)
11. Wu TJ, Lee LY, Yeh CN, et al. Surgical treatment and prognostic analysis for gastrointestinal stromal tumors (GISTs) of the small intestine: before the era of imatinib mesylate. BMC Gastroenterol. 2006;6:29.
12. Telkes G, Alfoldy F, Perner F, et al. Our experiences with surgical treatment of gastrointestinal stromal tumors [in Hungarian]. Magy Seb. 2004;57:257-260.
13. Nikfarjam M, Kimchi E, Shereef S, et al. Surgical outcomes of patients with gastrointestinal stromal tumors in the era of targeted drug therapy. J Gastrointest Surg. 2008;12:2023-2031.
14. Eisenberg BL, Judson I. Surgery and imatinib in the management of GIST: emerging approaches to adjuvant and neoadjuvant therapy. Ann Surg Oncol. 2004;11:465-475. (Pubitemid 40486727)
15. Eisenberg BL, Harris J, Blanke CD, et al. Phase II trial of neoadjuvant/ adjuvant imatinib mesylate (IM) for advanced primary and metastatic/recurrent operable gastrointestinal stromal tumor (GIST): early results of RTOG 0132/ACRIN 6665. J Surg Oncol. 2009;99:42-47.
16. Fiore M, Palassini E, Fumagalli E, et al. Preoperative imatinib mesylate for unresectable or locally advanced primary gastrointestinal stromal tumors (GIST). Eur J Surg Oncol. 2009;35:739-745.
17. Miettinen M, Sarlomo-Rikala M, Sobin LH, et al. Esophageal stromal tumors. A clinicopathologic, immunohistochemical, and molecular genetic study of 17 cases and comparison with esophageal leiomyomas and leiomyosarcomas. Am J Surg Pathol. 2000;24:211-222. (Pubitemid 30078710)
18. DeMatteo RP, Lewis JJ, Leung D, et al. Two hundred gastrointestinal stromal tumors: recurrence patterns and prognostic factors for survival. Ann Surg. 2000;231:51.
19. Bucher P, Egger JF, Gervaz P, et al. An audit of surgical management of gastrointestinal stromal tumors (GIST). Eur J Surg Oncol. 2006;32:310-314.
20. Emory TS, Sobin LH, Lukes L, et al. Prognosis of gastrointestinal smoothmuscle (stromal) tumors: dependence on anatomic site. Am J Surg Pathol. 1999;23:82-87. (Pubitemid 29025244)
21. Miyoshi K, Naito M, Ueno T, et al. Abnormal fluorine-18- fluorodeoxyglucose uptake in benign esophageal leiomyoma. Gen Thorac Cardiovasc Surg. 2009;57:629-632.
22. Ozan E, Oztekin O, Alacacioglu A, et al. Esophageal gastrointestinal stromal tumor with pulmonary and bone metastasis. Diagn Interv Radio. 2010;16: 217-220.
23. Dong C, Jun HC, Xiao JY, et al. Gastrointestinal stromal tumors of the rectum: clinical, pathologic, immunohistochemical characteristics and prognosis analysis. Scand J Gastroenterol. 2007;42:1221-1229. (Pubitemid 47537090)
24. Rishindra MR, Fleshman JW. Colorectal gastrointestinal stromal tumors: a brief review. Clin Colon Rectal Surg. 2006;19:69-77. (Pubitemid 43855638)
25. Changchien CR, Wu MC, Tasi WS, et al. Evaluation of prognosis for malignant rectal gastrointestinal stromal tumor by clinical parameters and immunohistochemical staining. Dis Colon Rectum. 2004;47:1922-1929. (Pubitemid 40064437)
26. Popescu LM, Hinescu ME, Ionescu N, et al. Interstitial cells of Cajal in pancreas. J Cell Mol Med. 2007;9:169-190.
27. Pauser U, Hinz S, Merz H, et al. Gastrointestinal stromal tumors with pseudocystic change micmicking a pancreatic tumor: two case reports. J Med Case Reports. 2009;3:7592.
28. Brown TH, Menon VS, Richards DG, et al. Gastrointestinal bleeding in a pregnant woman: mucinous cystic neoplasm of pancreas mimicking gastrointestinal stromal tumor of stomach. J Hepatobiliary Pancreat Surg. 2009; 16:681-683.
29. Harindhanavudhi T, Tanawuttiwat T, Pyle J, et al. Extra-gastrointestinal stromal tumor presenting as hemorrhagic pancreatic cyst diagnosed by EUSFNA. J Pancreas. 2009;10:189-191.
30. Van de raa F, Roskams T, Blyweert W, et al. Interstitial cells in the human prostate: a new therapeutic target? Prostate. 2003;56:250-255. (Pubitemid 36988745)
31. Shafik A, Shafik I, El-Sibai O. Identification of c-kit positive cells in the human prostate. Syst Biol Reprod Med. 2005;51:345-351.
32. Lang RJ, Klemm MF. Interstitial cell of Cajal-like cells in the upper urinary tract. J Cell Mol Med. 2005;9:543-556. (Pubitemid 44151946)
33. Lee CH, Lin YH, Lin HY, et al. Gastrointestinal stromal tumor of the prostate: a case report and literature review. Hum Pathol. 2006;37:1361-1365.
34. Herawi M, Montgomery EA, Epstein JI. Gastrointestinal stromal tumors (GISTs) on prostate needle biopsy: a clinicopathologic study of 8 cases. Am J Surg Pathol. 2006;30:1389-1395. (Pubitemid 44655472)
35. Shabaik A. Nonepithelial tumors and tumor-like lesions of the prostate gland. Crit Rev Clin Lab Sci. 2003;40:429-472. (Pubitemid 37204501)
36. Vanderaa F. Gastrointestinal stromal tumor of the prostate. Urology. 2005; 65:388.
37. Hansel DE, Herawi M, Montgomery E, et al. Spindle cell lesions of the adult prostate. Mod Pathol. 2007;20:148-158. (Pubitemid 44967960)
38. Reith JD, Goldblum JR, Lyles RH, et al. Extragastrointestinal (soft tissue) stromal tumor: an analysis of 48 cases with emphasis on histological predictors of outcome. Mod Pathol. 2000;13:577-585. (Pubitemid 30332111)
39. Sezer A, Yagci MA, Hatipoglu AR, et al. A rare cause of intestinal obstruction due to an exophytic gastrointestinal stromal tumor of the small bowel. Signa Vitae. 2009;4:32-34.
40. Gupta S, Punia R, Kaushik R. Gastrointestinal stromal tumor of the colon presenting with intestinal obstruction. Indian J Cancer. 2004;41:175-177. (Pubitemid 40203363)
41. Vasiliadis K, Kogopoulos E, Katsamakas M, et al. Ileoileal intussusception induced by a gastrointestinal stromal tumor. World J Surg Oncol. 2008;6:133.
42. Yoshimura N, Ohara H, Miyabe K, et al. A case of gastrointestinal stromal tumor with spontaneous rupture in the greater omentum. Int Semin Surg Oncol. 2008;5:19.
43. Hirasaki S, Fujita K, Matsubara M, et al. A ruptured large extraluminal ileal gastrointestinal stromal tumor causing hemoperitoneum. World J Gastroenterol. 2008;14:2928-2931.
44. Wong CS, Chan T, Chu YC, et al. Esophageal gastrointestinal stromal tumor presenting with rupture into pleural cavity. Hong Kong Med J. 2007;13:478-481. (Pubitemid 351206684)
45. Miettinen M, Lasota J. Gastrointestinal stromal tumors: review on morphology, molecular pathology, prognosis, and differential diagnosis. Arch Pathol Lab Med. 2006;130:1466-1478. (Pubitemid 44520713)
46. Miettinen M, Lasota J, Sobin LH. Gastrointestinal stromal tumors of the stomach in children and young adults. Am J Surg Pathol. 2005;29:1373-1381.
47. Agaimy A, Wunsch PH. Lymph node metastasis in gastrointestinal stromal tumors (GIST) occurs preferentially in young patients < or =40 years: an overview based on our case material and the literature. Langenbecks Arch Surg. 2009;374:375-381.
48. Janeway KA, Albritton KH, Van Den Abbeele AD, et al. Sunitinib treatment in pediatric patients with advanced GIST following failure of imatinib. Pediatr Blood Cancer. 2009;52:767-771.
49. Canda AE, Ozsoy Y, Nalbant OA, et al. Gastrointestinal stromal tumor of the stomach with lymph node metastasis. World J Surg Oncol. 2008;4:97.
50. El Demellawy D, Shokry P, Ing A, et al. Polypoid gastrointestinal stromal tumor of the small bowel metastasizing to mesenteric lymph nodes: a case report. Pathol Res Pract. 2008;204:197-201.
51. Bucher P, Villiger P, Egger JF, et al. Management of gastrointestinal stromal tumor: from diagnosis to treatment. Swiss Med Wkly. 2004;134:145-153. (Pubitemid 38418933)
52. Schuler M, Zeile M, Pink D, et al. Incidence of bone metastasis in GIST: a single center analysis of 307 patients with metastatic disease. J Clin Oncol. 2008;26(suppl). Abstract 10565.
53. Chu YC, Wong CS. Bone metastases from gastrointestinal stromal tumor: correlation with positron emission tomography- computed tomography. J HK Coll Radiol. 2009;11:172-175.
54. Lau S, Tam KF, Kam CK, et al. Imaging of gastrointestinal stromal tumour (GIST). Clin Radiol. 2004;59:487-498. (Pubitemid 38735554)
55. King MD. The radiology of gastrointestinal stromal tumors (GIST). Cancer Imaging. 2005;5:150-156.
56. Hong X, Choi H, Loyer EM, et al. Gastrointestinal stromal tumor: role of CT in diagnosis and in response evaluation and surveillance after treatment with imatinib. Radiographics. 2006;26:481-495. (Pubitemid 43515319)
57. Choi H, Charnsangavej C, Faria SC, et al. Correlation of computed tomography and positron emission tomography in patients with metastatic gastrointestinal stromal tumor treated at a single institution with imatinib mesylate: proposal of new computed tomography response criteria. J Clin Oncol. 2007;25:1753-1759. (Pubitemid 46797957)
58. Schlemmer M, Sourbron SP, Schinwald N, et al. Perfusion patterns of metastatic gastrointestinal stromal tumor lesions under specific molecular therapy. Eur J Radiol. In press.
59. Zaknun JJ, Kendler D, Moncayo R, et al. F-18 FDG PET for assessing tyrosine kinase-related signal transduction inhibition in a GIST c-kit-positive tumor patient by imatinib. Clin Nucl Med. 2005;30:749-751. (Pubitemid 41552125)
60. Banzo I, Quirce R, Martinez-Rodriguez I, et al. F-18 FDG PET/CT assessment of gastrointestinal stromal tumor response to sunitinib malate therapy. Clin Nucl Med. 2008;33:211-212. (Pubitemid 351301560)
61. Shinto A, Nair N, Dutt A, et al. Early response assessment in gastrointestinal stromal tumors with FDG PET scan 24 hours after a single dose of imatinib. Clin Nucl Med. 2008;33:486-487.
62. Eslamy HK, Quon A. PET/CT imaging of gastrointestinal stromal tumor with calcified peritoneal implants after imatinib therapy. Clin Nucl Med. 2008;33: 864-865.
63. Gayed I, Vu T, Iyer R, et al. The role of 18F-FDG PET in staging and early prediction of response to therapy of recurrent gastrointestinal stromal tumors. J Nucl Med. 2004;45:17-21. (Pubitemid 47611603)
64. Antoch G, Kanja J, Bauer S, et al. Comparison of PET, CT, and dual-modality PET/CT imaging for monitoring of imatinib (STI571) therapy in patients with gastrointestinal stromal tumors. J Nucl Med. 2004;45:357-365. (Pubitemid 47618607)
65. Choi H. Response evaluation of gastrointestinal stromal tumors. Oncologist. 2008;13(suppl 2):4-7.
66. Shankar S, Dundamadappa SK, Karam AR, et al. Imaging of gastrointestinal stromal tumors before and after Imatinib Mesylate therapy. Acta Radiol. 2009;8:837-844.